CUE Cue Biopharma

P/E --
Forward P/E --
Price/Sales 3.42
Beta 2.47
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Cue Biopharma is trading 5.2% down today following its reverse split and private placement

Cue Biopharma is trading at $29.32 (5.2% down) as investors digest recent capital structure changes, including a reverse stock split and a private...

🟢 Cue Biopharma is trading 6.4% up today following a reverse stock split and $50 million private placement

Cue Biopharma is trading 6.4% up at $32.90 in pre-market action as the market reacts to significant changes in the company's capital structure. • The company...

🔴 Cue Biopharma is trading 11.1% down

Cue Biopharma is trading at $32.71, down 11.1% from a comparison close of $36.78 during regular trading. This is a price-action follow-up, so a separate...

🔴 Cue Biopharma is trading 6.1% down today after pricing $50M private placement at a discount

Cue Biopharma is trading 6.1% down at $34.55 after pricing a $50 million private placement at a discount to its recent market value. • The offering is priced...

🔴 Cue Biopharma is trading 14% down today after $50M private placement pricing

Cue Biopharma is trading at $31.50 (14% down) after announcing a $50 million private placement of common stock and pre-funded warrants priced at approximately...

Cue Biopharma Announces $50 Million Private Placement Financing

Cue Biopharma Announces $50 Million Private Placement Financing

Cue Biopharma, Inc. has entered into a securities purchase agreement with accredited investors for a private placement expected to generate gross proceeds of...

🟢 Cue Biopharma is trading 12.1% up today after announcing a $50M private placement

Cue Biopharma is trading 12.1% up at $40.92 after announcing a $50 million private placement priced at $33.21 per share with accredited investors. • The...

🟢 Cue Biopharma is trading 10.5% up

Cue Biopharma is trading at $40.34, up 10.5% from a comparison close of $36.51 during pre-market. This is a price-action follow-up, so a separate catalyst may...

Cue Biopharma Lands $50 Million From Big-Name Biotech Funds — But Can a Cash-Burning Micro-Cap Justify a 42% Weekly Rally?

Cue Biopharma Lands $50 Million From Big-Name Biotech Funds — But Can a Cash-Burning Micro-Cap Justify a 42% Weekly Rally?

Shares of Cue Biopharma surged 9.6% in pre-market trading to $40.01 after the clinical-stage drugmaker announced a $50 million private placement — its second...

🟢 Cue Biopharma is trading 9.6% up today after announcing a $50M private placement

Cue Biopharma is trading 9.6% up at $40.01 in pre-market after announcing a $50 million private placement of common stock and pre-funded warrants to...

🔴 Cue Biopharma is trading 10.2% down

Cue Biopharma is trading at $31.75, down 10.2% from a comparison close of $35.35 during regular trading. This is a price-action follow-up, so a separate...

🔴 Cue Biopharma is trading 5.2% down today as investors take profits following its reverse split rally

Cue Biopharma is trading 5.2% down at $33.51 as the stock pulls back following a sharp multi-session rally triggered by its 1-for-30 reverse stock split. •...

🟢 CUE is trading 6% up today on continued momentum from its recent reverse stock split rally

CUE is trading at $35.38 (+5.94%) as it maintains upward momentum following its recent 1-for-30 reverse stock split. • The stock has exhibited significant...

🔴 CUE is trading 6.7% down today on profit-taking after post-split rally

CUE is trading at $31.16 (6.7% down) today, retreating as investors lock in gains following a multi-day surge triggered by its reverse stock split. • The...

🔴 CUE is trading 6% down today on profit-taking after recent post-split rally

CUE is trading 6% down today at $30.68 as the stock undergoes a pullback following a sharp multi-day run-up. • The decline follows significant gains triggered...

🔴 CUE makes sharp 10.6% drop

CUE is trading at $28.23, down 10.6% versus the comparison close of $31.56 during regular trading. This is a price-movement alert; no separate company-specific...

🔴 CUE is trading 6% down today on profit-taking following a sharp multi-day rally

CUE is trading at approximately $29.68 (6% down) as the stock experiences profit-taking and volatility typical of small-cap biotech following a series of major...

🟢 CUE makes sharp 13.7% jump

CUE is trading at $34.59, up 13.7% versus the comparison close of $30.43 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 CUE makes sharp 11.4% jump

CUE is trading at $28.29, up 11.4% versus the comparison close of $25.39 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 CUE surges 5.5% today after inclusion in Russell Microcap Index, following prior strategic updates

• Cue Biopharma was added to the Russell Microcap Index on June 29, 2026. • This follows earlier strategic developments including a $30 million private...